المؤلفون: Robin Alec Fairhurst, Joseph D. Fullerton, David Andrew Sandham, Heinz E. Moser, Mauro Zurini, Sandra Haberthuer, Darryl Brynley Jones, Mark Dodds, Julia Hatto, Gurdip Bhalay, Colin Howes, Paul Nicklin, Simon J. Watson, David Farr, Reto Naef, Irene Muller, Andrew Dunstan, Nichola J. Arnold, Nicholas James Devereux, Morris Tweed, Angela Glen, Katharine L. Turner, Beate Leuenberger, David Beer, Sylvie Gomez, Ruth Arnold, Thomas H. Keller, Stephen Paul Collingwood, Sarah Craig

المصدر: Bioorganic & Medicinal Chemistry Letters. 17:2376-2379

مصطلحات موضوعية: Male, Clinical Biochemistry, Biological Availability, Pharmaceutical Science, Biochemistry, Inhibitory Concentration 50, Structure-Activity Relationship, chemistry.chemical_compound, Dogs, Erectile Dysfunction, 3',5'-Cyclic-GMP Phosphodiesterases, In vivo, Drug Discovery, Animals, Humans, Protein Isoforms, Structure–activity relationship, Pharmacokinetics, Enzyme Inhibitors, Molecular Biology, Cyclic Nucleotide Phosphodiesterases, Type 5, chemistry.chemical_classification, Organic Chemistry, Biological activity, Xanthine, In vitro, Bioavailability, Enzyme, chemistry, Xanthines, cGMP-specific phosphodiesterase type 5, Molecular Medicine, Cattle, sense organs

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e21375e8e7ea71d3deb6323b8cc3fb4
https://doi.org/10.1016/j.bmcl.2006.11.019